Rxsight Inc (RXST NASDAQ) stock market data APIs
$25.171
0.24(1%)
as of March 24, 2025
Rxsight Inc Financial Data Overview
RxSight, Inc., a commercial-stage medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. The company's RxSight system includes RxSight Light Adjustable Lens (LAL), an intraocular lens made of photosensitive material that changes shape in response to specific patterns of ultraviolet, which can be adjusted to improve uncorrected visual acuity; and RxSight light delivery device, an office-based light treatment device that delivers UV light in a programmed pattern to modify the LAL based on the visual correction needed to achieve desired vision after cataract surgery. The company was formerly known as Calhoun Vision, Inc. and changed its name to RxSight, Inc. in February 2017. RxSight, Inc. was incorporated in 1997 and is headquartered in Aliso Viejo, California.
Prev. Close
24.93
Open
25.171
High
25.3545
Low
24.868
52 wk Range
24.09-66.54
Market Cap
1 006 M
Shares Outstanding
40 491 K
Revenue
140 M
EPS
0.03
Beta
1.22
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Rxsight Inc data using free add-ons & libraries
Get Rxsight Inc Fundamental Data
Rxsight Inc Fundamental data includes:
- Net Revenue: 140 M
- EBITDA: -33 283 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-02-26
- EPS/Forecast: -0.0086
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Rxsight Inc News
New
RxSight, Inc. (NASDAQ:RXST) Just Reported, And Analysts Assigned A US$44.80 Price Target
Last week, you might have seen that RxSight, Inc. (NASDAQ:RXST) released its annual result to the market. The early response was not positive, with shares down 7.0% to US$28.21 in the past week. Reven...
RxSight Full Year 2024 Earnings: EPS Beats Expectations
RxSight (NASDAQ:RXST) Full Year 2024 Results Key Financial Results Revenue: US$139.9m (up 57% from FY 2023). Net loss: US$27.5m (loss narrowed by 44% from FY 2023). US$0.71 loss per share (improved ...
RxSight Inc (RXST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ...
Revenue: $40.2 million in Q4 2024, up 41% year-over-year. LAL Revenue: $28.5 million in Q4 2024, up 60% year-over-year. LDD Revenue: $10.7 million in Q4 2024. Gross Margin: 71.6% in Q4 2024, up from 6...
RxSight, Inc. (RXST) Misses Q4 Earnings Estimates
RxSight, Inc. (RXST) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.10 per share. This compares to loss of $0.26 per share a year ago. These figures ar...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
